Guest guest Posted May 26, 2011 Report Share Posted May 26, 2011 Hepatitis C 'Silent Epidemic' in US Needs More Funding, Researcher Says Bloomberg By Meg Tirrell - Wed May 25 17:00:00 GMT 2011 Hepatitis C, a disease that affects at least 5 million Americans, may be growing at a greater rate than reported as a “silent epidemic” of the virus spreads among younger people, according to a New York ... See all stories on this topic » Anadys Highlights ANA773 Data to be Presented at ASCO PR Newswire (press release) " While Anadys is focusing its development efforts in the area of hepatitis C, we continue to believe that ANA773 holds promise for the treatment of a range of cancer types, particularly in combination with other agents such as monoclonal antibodies ... See all stories on this topic » Achillion's hep C drug in human trials Hartford Business New Haven drug developer Achillion Pharmaceuticals Inc. has launched its first human trial of one of its treatment for chronic hepatitis C. The company says the double-blind Phase 1 study of its ACH-2684 protease inhibitor compound involves stepped-up ... See all stories on this topic » Pa. practice tells patients it reused needles The Herald-Mail Accompanying the letter was a laboratory outpatient form for tests for Hepatitis Bs Ag, Hepatitis C and HIV. A Greencastle, Pa., resident who received the letter said Urology Associates paid for his blood test, which did not indicate he had infectious ... See all stories on this topic » Clinic and nurse support for hepatitis C patients Western Advocate A NEW medical clinic is open to receive referrals for hepatitis C patients who require assessment, treatment and follow-up services in Bathurst. Dr Darryl MacKender and Dr Bruce McGarity will be seeing patients at the Division of General Practice on ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 26, 2011 Report Share Posted May 26, 2011 Hepatitis C 'Silent Epidemic' in US Needs More Funding, Researcher Says Bloomberg By Meg Tirrell - Wed May 25 17:00:00 GMT 2011 Hepatitis C, a disease that affects at least 5 million Americans, may be growing at a greater rate than reported as a “silent epidemic” of the virus spreads among younger people, according to a New York ... See all stories on this topic » Anadys Highlights ANA773 Data to be Presented at ASCO PR Newswire (press release) " While Anadys is focusing its development efforts in the area of hepatitis C, we continue to believe that ANA773 holds promise for the treatment of a range of cancer types, particularly in combination with other agents such as monoclonal antibodies ... See all stories on this topic » Achillion's hep C drug in human trials Hartford Business New Haven drug developer Achillion Pharmaceuticals Inc. has launched its first human trial of one of its treatment for chronic hepatitis C. The company says the double-blind Phase 1 study of its ACH-2684 protease inhibitor compound involves stepped-up ... See all stories on this topic » Pa. practice tells patients it reused needles The Herald-Mail Accompanying the letter was a laboratory outpatient form for tests for Hepatitis Bs Ag, Hepatitis C and HIV. A Greencastle, Pa., resident who received the letter said Urology Associates paid for his blood test, which did not indicate he had infectious ... See all stories on this topic » Clinic and nurse support for hepatitis C patients Western Advocate A NEW medical clinic is open to receive referrals for hepatitis C patients who require assessment, treatment and follow-up services in Bathurst. Dr Darryl MacKender and Dr Bruce McGarity will be seeing patients at the Division of General Practice on ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 26, 2011 Report Share Posted May 26, 2011 Hepatitis C 'Silent Epidemic' in US Needs More Funding, Researcher Says Bloomberg By Meg Tirrell - Wed May 25 17:00:00 GMT 2011 Hepatitis C, a disease that affects at least 5 million Americans, may be growing at a greater rate than reported as a “silent epidemic” of the virus spreads among younger people, according to a New York ... See all stories on this topic » Anadys Highlights ANA773 Data to be Presented at ASCO PR Newswire (press release) " While Anadys is focusing its development efforts in the area of hepatitis C, we continue to believe that ANA773 holds promise for the treatment of a range of cancer types, particularly in combination with other agents such as monoclonal antibodies ... See all stories on this topic » Achillion's hep C drug in human trials Hartford Business New Haven drug developer Achillion Pharmaceuticals Inc. has launched its first human trial of one of its treatment for chronic hepatitis C. The company says the double-blind Phase 1 study of its ACH-2684 protease inhibitor compound involves stepped-up ... See all stories on this topic » Pa. practice tells patients it reused needles The Herald-Mail Accompanying the letter was a laboratory outpatient form for tests for Hepatitis Bs Ag, Hepatitis C and HIV. A Greencastle, Pa., resident who received the letter said Urology Associates paid for his blood test, which did not indicate he had infectious ... See all stories on this topic » Clinic and nurse support for hepatitis C patients Western Advocate A NEW medical clinic is open to receive referrals for hepatitis C patients who require assessment, treatment and follow-up services in Bathurst. Dr Darryl MacKender and Dr Bruce McGarity will be seeing patients at the Division of General Practice on ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Guest guest Posted May 26, 2011 Report Share Posted May 26, 2011 Hepatitis C 'Silent Epidemic' in US Needs More Funding, Researcher Says Bloomberg By Meg Tirrell - Wed May 25 17:00:00 GMT 2011 Hepatitis C, a disease that affects at least 5 million Americans, may be growing at a greater rate than reported as a “silent epidemic” of the virus spreads among younger people, according to a New York ... See all stories on this topic » Anadys Highlights ANA773 Data to be Presented at ASCO PR Newswire (press release) " While Anadys is focusing its development efforts in the area of hepatitis C, we continue to believe that ANA773 holds promise for the treatment of a range of cancer types, particularly in combination with other agents such as monoclonal antibodies ... See all stories on this topic » Achillion's hep C drug in human trials Hartford Business New Haven drug developer Achillion Pharmaceuticals Inc. has launched its first human trial of one of its treatment for chronic hepatitis C. The company says the double-blind Phase 1 study of its ACH-2684 protease inhibitor compound involves stepped-up ... See all stories on this topic » Pa. practice tells patients it reused needles The Herald-Mail Accompanying the letter was a laboratory outpatient form for tests for Hepatitis Bs Ag, Hepatitis C and HIV. A Greencastle, Pa., resident who received the letter said Urology Associates paid for his blood test, which did not indicate he had infectious ... See all stories on this topic » Clinic and nurse support for hepatitis C patients Western Advocate A NEW medical clinic is open to receive referrals for hepatitis C patients who require assessment, treatment and follow-up services in Bathurst. Dr Darryl MacKender and Dr Bruce McGarity will be seeing patients at the Division of General Practice on ... See all stories on this topic » Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.